DeltaScan
Validation Data
Proof of concept study
.png)
56
Patients

Validation study
.png)
145
Patients
321 EEGs

Further clinical detection benefits
Time-to-Detection
The first validation study provided multiple measurements per patient over three consecutive postoperative days. Analysis of this data shows a detection benefit of 1-1.5 days for DeltaScan over usual care.
Data on file
Making the invisible visible
In each study, it was found that often cases of AE do not coincide with clinical signs of delirium. EEG experts as well as DeltaScan find brain dysfunction (polymorphic delta activity) which is a prompt for further clinical workup.
Data on file
Interested? Let's get in touch!
Get in touch to learn how you can reshape acute encephalopathy and delirium care delivery.
pageversion: 3.0